India's Lupin seeks biosimilar, lung drug partners Reuters MUMBAI (Reuters) - Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said. The United States and Japan were the most ... |
